GP100 (209–217)

• Description :

  GP100 (209-217) is a 9-aa peptide derived from human gp100 beginning at position 20[1].

• UNSPSC :

  12352209

• Target :

  Others

• Type :

  Peptides

• Related Pathways :

  Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/gp100-209-217-1.html

• Solubility :

  10 mM in DMSO

• Smiles :

  CC[C@H](C)[C@H](N)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CCC(N)=O)C(N[C@@H](C(C)C)C(N1[C@@H](CCC1)C(N[C@H](C(N[C@@H](CO)C(N[C@H](C(O)=O)C(C)C)=O)=O)CC2=CC=CC=C2)=O)=O)=O)=O)=O)=O

• Molecular Formula :

  C46H72N10O15

• Molecular Weight :

  1005.12

• References & Citations :

  [1]Changes in the fine specificity of gp100209–217-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [162558-10-3]